Immatics N.V.
IMTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001809196
In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Immatics N.V. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- +13 vs. Q1 2024
- Shares held
- 76.6M
- +5.36M (+7.5%) vs. Q1 2024
- Total value
- $890.3M
- +$141.4M (+18.9%) vs. Q1 2024
- New holders
- 23
- 29 more added
- Sold out
- 10
- 26 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $1.01B |
| Q1 2026 | 84 | $1.06B |
| Q4 2025 | 75 | $1.07B |
| Q3 2025 | 63 | $787.2M |
| Q2 2025 | 70 | $500.9M |
| Q1 2025 | 76 | $412.1M |
| Q4 2024 | 85 | $656.0M |
| Q3 2024 | 91 | $865.8M |
| Q2 2024 | 90 | $890.3M |
| Q1 2024 | 77 | $748.9M |
| Q4 2023 | 76 | $522.3M |
| Q3 2023 | 74 | $501.0M |
| Q2 2023 | 68 | $472.7M |
| Q1 2023 | 65 | $238.5M |
| Q4 2022 | 63 | $296.5M |
| Q3 2022 | 54 | $221.4M |
| Q2 2022 | 49 | $186.9M |
| Q1 2022 | 47 | $173.0M |
| Q4 2021 | 49 | $309.5M |
| Q3 2021 | 51 | $292.1M |
| Q2 2021 | 50 | $243.4M |
| Q1 2021 | 44 | $237.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Immatics N.V.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 10,000,000 | $116.2M | 1.80% | 00.0% | Unchanged |
| Wellington Management Group LLP | 9,536,634 | $110.8M | 0.02% | +1,210,302+14.5% | Added |
| Perceptive Advisors LLC | 8,086,159 | $94.0M | 2.27% | +3,503,750+76.5% | Added |
| T. Rowe Price Investment Management, Inc. | 7,433,707 | $86.4M | 0.05% | +1,129,035+17.9% | Added |
| Baker Bros. Advisors LP | 6,443,398 | $74.9M | 0.96% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,639,562 | $42.3M | 0.01% | +414,202+12.8% | Added |
| Paradigm Biocapital Advisors LP | 3,421,965 | $39.8M | 1.52% | +603,057+21.4% | Added |
| Woodline Partners LP | 3,262,010 | $37.9M | 0.36% | +888,023+37.4% | Added |
| Vestal Point Capital, LP | 2,750,000 | $32.0M | 2.38% | +1,550,000+129.2% | Added |
| OrbiMed Advisors LLC | 2,006,381 | $23.3M | 0.50% | +236,673+13.4% | Added |
| Goldman Sachs Group Inc | 1,752,355 | $20.4M | 0.00% | −56,914−3.1% | Reduced |
| Ra Capital Management, L.P. | 1,750,000 | $20.3M | 0.27% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,152,456 | $13.4M | 0.63% | +1,152,456 | New |
| Suvretta Capital Management, LLC | 946,563 | $11.0M | 0.45% | 00.0% | Unchanged |
| Citadel Advisors LLC | 885,407 | $10.3M | 0.01% | +183,920+26.2% | Added |
| Wasatch Advisors Inc | 843,272 | $9.80M | 0.05% | +112,878+15.5% | Added |
| 683 Capital Management, LLC | 815,000 | $9.47M | 0.99% | −85,000−9.4% | Reduced |
| Sofinnova Investments, Inc. | 796,704 | $9.26M | 0.58% | −1,366,942−63.2% | Reduced |
| Nantahala Capital Management, LLC | 787,974 | $9.16M | 0.92% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 751,252 | $8.73M | 0.02% | +270,000+56.1% | Added |
| Sphera Funds Management Ltd. | 731,111 | $8.50M | 1.38% | +65,000+9.8% | Added |
| University of Texas/Texas Am Investment Managment Co | 697,431 | $8.10M | 1.58% | −697,431−50.0% | Reduced |
| BlackRock Inc. | 690,761 | $8.03M | 0.00% | +32,371+4.9% | Added |
| Artisan Partners Limited Partnership | 688,484 | $8.00M | 0.01% | −466−0.1% | Reduced |
| StemPoint Capital LP | 502,207 | $5.84M | 1.72% | +10,281+2.1% | Added |
| Walleye Capital LLC | 419,393 | $4.87M | 0.05% | −240,786−36.5% | Reduced |
| MPM Oncology Impact Management LP | 417,810 | $4.85M | 0.75% | +417,810 | New |
| Avidity Partners Management LP | 393,100 | $4.57M | 0.19% | +393,100 | New |
| Zimmer Partners, LP | 360,000 | $4.18M | 0.08% | −37,000−9.3% | Reduced |
| TD Asset Management Inc | 357,526 | $4.15M | 0.00% | +37,770+11.8% | Added |
| Morgan Stanley | 324,441 | $3.77M | 0.00% | −188,456−36.7% | Reduced |
| JPMorgan Chase & Co | 321,760 | $3.74M | 0.00% | +50,310+18.5% | Added |
| Affinity Asset Advisors, LLC | 300,000 | $3.49M | 0.55% | −50,000−14.3% | Reduced |
| Schroder Investment Management Group | 280,447 | $3.26M | 0.00% | +142,708+103.6% | Added |
| Cubist Systematic Strategies, LLC | 206,920 | $2.40M | 0.04% | +206,920 | New |
| Gratus Capital LLC | 205,390 | $2.39M | 0.10% | +10,114+5.2% | Added |
| Platinum Investment Management Ltd | 203,614 | $2.37M | 0.10% | −85,075−29.5% | Reduced |
| State Street Corp | 202,492 | $2.35M | 0.00% | +202,492 | New |
| Aquilo Capital Management, LLC | 200,000 | $2.32M | 2.24% | +200,000 | New |
| Samsara BioCapital, LLC | 198,000 | $2.30M | 0.48% | −198,000−50.0% | Reduced |
| Manufacturers Life Insurance Company, The | 150,769 | $1.75M | 0.00% | +18,354+13.9% | Added |
| DAFNA Capital Management LLC | 145,000 | $1.68M | 0.40% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 133,284 | $1.55M | 0.00% | −504,670−79.1% | Reduced |
| Two Sigma Investments, LP | 130,999 | $1.52M | 0.00% | −89,124−40.5% | Reduced |
| Crestline Management, LP | 126,325 | $1.47M | 0.12% | +4,289+3.5% | Added |
| Geode Capital Management, LLC | 110,217 | $1.28M | 0.00% | +22,251+25.3% | Added |
| Two Sigma Advisers, LP | 100,300 | $1.17M | 0.00% | −57,200−36.3% | Reduced |
| HighVista Strategies LLC | 77,821 | $904.3K | 0.33% | +77,821 | New |
| Voloridge Investment Management, LLC | 73,302 | $851.8K | 0.00% | +73,302 | New |
| Millennium Management LLC | 58,365 | $678.2K | 0.00% | +42,477+267.4% | Added |
| Jane Street Group, LLC | 55,531 | $645.3K | 0.00% | +22,833+69.8% | Added |
| Verition Fund Management LLC | 55,283 | $642.4K | 0.00% | +55,283 | New |
| Trexquant Investment LP | 55,008 | $639.2K | 0.01% | +55,008 | New |
| Tudor Investment Corp Et Al | 51,379 | $597.0K | 0.01% | +25,946+102.0% | Added |
| Ikarian Capital, LLC | 49,415 | $574.2K | 0.18% | 00.0% | Unchanged |
| Jump Financial, LLC | 48,991 | $569.3K | 0.01% | +48,991 | New |
| Bank of America Corp | 44,724 | $519.7K | 0.00% | +14,481+47.9% | Added |
| Northern Trust Corp | 36,616 | $425.5K | 0.00% | −3,312−8.3% | Reduced |
| New York State Common Retirement Fund | 31,156 | $362.0K | 0.00% | +405+1.3% | Added |
| Mercer Global Advisors Inc | 29,877 | $358.5K | 0.00% | 00.0% | Unchanged |
| J. Goldman & Co LP | 29,538 | $343.2K | 0.01% | −33,094−52.8% | Reduced |
| XTX Topco Ltd | 27,587 | $320.6K | 0.03% | +27,587 | New |
| Engineers Gate Manager LP | 25,342 | $294.5K | 0.01% | +1,510+6.3% | Added |
| Qube Research & Technologies Ltd | 22,275 | $258.8K | 0.00% | −202,633−90.1% | Reduced |
| Corton Capital Inc. | 21,339 | $248.0K | 0.13% | +21,339 | New |
| Algert Global LLC | 20,818 | $241.9K | 0.01% | +20,818 | New |
| Bayesian Capital Management, LP | 20,552 | $238.8K | 0.03% | +20,552 | New |
| AlphaCentric Advisors LLC | 20,000 | $232.4K | 0.17% | +2,500+14.3% | Added |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 19,944 | $231.7K | 0.00% | +19,944 | New |
| Exchange Traded Concepts, LLC | 18,111 | $210.4K | 0.01% | −5,634−23.7% | Reduced |
| Nan Fung Group Holdings Ltd | 15,700 | $182.4K | 0.19% | 00.0% | Unchanged |
| Forefront Analytics, LLC | 11,987 | $139.3K | 0.07% | +11,987 | New |
| Pale Fire Capital SE | 11,524 | $133.9K | 0.02% | +11,524 | New |
| Quarry LP | 8,500 | $98.8K | 0.04% | +8,500 | New |
| Virtus ETF Advisers LLC | 6,990 | $81.2K | 0.04% | −1,847−20.9% | Reduced |
| UBS Group AG | 3,762 | $43.7K | 0.00% | −394−9.5% | Reduced |
| Citigroup Inc | 1,537 | $17.9K | 0.00% | −2,046−57.1% | Reduced |
| Lazard Asset Management LLC | 1,544 | $17.0K | 0.00% | −4,184−73.0% | Reduced |
| Barclays PLC | 1,434 | $16.7K | 0.00% | −126−8.1% | Reduced |
| nVerses Capital, LLC | 1,000 | $11.6K | 0.01% | −400−28.6% | Reduced |
| Abich Financial Wealth Management LLC | 900 | $10.5K | 0.01% | +900 | New |
| Huntington National Bank | 701 | $8.15K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 563 | $6.54K | 0.00% | +463+463.0% | Added |
| US Bancorp | 437 | $5.08K | 0.00% | −74−14.5% | Reduced |
| Royal Bank of Canada | 147 | $2.00K | 0.00% | −22−13.0% | Reduced |
| GWM Advisors LLC | 104 | $1.21K | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 80 | $930 | 0.00% | 00.0% | Unchanged |
| Bell Investment Advisors, Inc | 45 | $523 | 0.00% | +45 | New |
| CIBC Private Wealth Group, LLC | 27 | $320 | 0.00% | +27 | New |
| Wells Fargo & Company | 14 | $163 | 0.00% | +14 | New |
| VR Adviser, LLC | 0 | $0 | 0.00% | −1,750,000−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −848,751−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −470,285−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −225,023−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −24,437−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,043−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,967−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,874−100.0% | Sold out |